All posts tagged
More News! Allergan sees Patient Deaths, New Alzheimer’s Targets?
Can Roche & MorphoSys beat the odds in new Alzheimer’s Phase III Trials?
This Spanish Biotech is Detecting Alzheimer’s before Symptoms Appear
French Biotech bids for Crowdfunding in Neurodegenerative Disease
A Dutch University Hospital has Halted Amyloid Beta Drug Studies
10 Hot European Biotechs to Observe in 2017 🚀
The Largest Deals, Fundraising and Exits of 2016 in European Biotech
The 8 Biggest Biotech Medical Fails of 2016 in Europe
What does ‘Anti-Aging Treatment’ mean in Biotech?
Evotec closes the year partnering with Celgene to treat Alzheimer’s
Following Eli Lilly’s Failure, what’s Next in Alzheimer’s Treatments?
Drugging the Undruggable: New Acquisition to Boost GPCR Drugs
Labiotech UG, All Rights Reserved -
Send this to friend